Shares of SciClone Pharma (SCLN) resume trading down nearly 12%
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Join SI Premium – FREE
Shares of SciClone Pharma (Nasdaq: SCLN) resume trading down nearly 12 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stars are aligning for this China AI stock: Barclays
- Goldman flags 2 Japanese tech stocks to buy
- BofA sees a stronger path to sustainable growth for this work platform name
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
